Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11


A latent genetic subtype of major depression identified by whole-exome genotyping data in a Mexican-American cohort.

Yu C, Arcos-Burgos M, Licinio J, Wong ML.

Transl Psychiatry. 2017 May 16;7(5):e1134. doi: 10.1038/tp.2017.102.


Prospective Associations between Depression and Obesity for Adolescent Males and Females- A Systematic Review and Meta-Analysis of Longitudinal Studies.

Mannan M, Mamun A, Doi S, Clavarino A.

PLoS One. 2016 Jun 10;11(6):e0157240. doi: 10.1371/journal.pone.0157240. eCollection 2016. Review.


Astrocytic adenosine: from synapses to psychiatric disorders.

Hines DJ, Haydon PG.

Philos Trans R Soc Lond B Biol Sci. 2014 Oct 19;369(1654):20130594. doi: 10.1098/rstb.2013.0594. Review.


A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents.

DelBello MP, Hochadel TJ, Portland KB, Azzaro AJ, Katic A, Khan A, Emslie G.

J Child Adolesc Psychopharmacol. 2014 Aug;24(6):311-7. doi: 10.1089/cap.2013.0138. Epub 2014 Jun 23.


Reducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy.

Culpepper L.

Prim Care Companion CNS Disord. 2013;15(5). pii: PCC.13r01515. doi: 10.4088/PCC.13r01515. Epub 2013 Oct 31.


Behavioral activation for the treatment of atypical depression: a pilot open trial.

Weinstock LM, Munroe MK, Miller IW.

Behav Modif. 2011 Jul;35(4):403-24. doi: 10.1177/0145445511405646. Epub 2011 Apr 19.


Atypical depression.

Singh T, Williams K.

Psychiatry (Edgmont). 2006 Apr;3(4):33-9.


Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Bortolato M, Chen K, Shih JC.

Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1527-33. doi: 10.1016/j.addr.2008.06.002. Epub 2008 Jul 4. Review.


The role of monoamine oxidase inhibitors in current psychiatric practice.

Fiedorowicz JG, Swartz KL.

J Psychiatr Pract. 2004 Jul;10(4):239-48.

Supplemental Content

Support Center